Hoth Therapeutics, Inc.
HOTH
$0.8902
$0.02152.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.19M | -7.77M | -7.72M | -7.96M | -8.11M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 804.80K | 580.30K | 453.50K | 622.70K | 146.40K |
| Change in Net Operating Assets | 405.20K | -833.60K | -754.30K | -541.00K | -487.40K |
| Cash from Operations | -6.98M | -8.02M | -8.02M | -7.88M | -8.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.74M | 3.68M | 6.09M | 2.41M | 11.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.74M | 3.68M | 6.09M | 2.41M | 11.32M |
| Foreign Exchange rate Adjustments | -18.30K | 533.80K | 45.40K | -6.10K | -6.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.25M | -3.81M | -1.89M | -5.48M | 2.86M |